Clinical and laboratory markers of the new coronavirus disease SARS-CoV-2 COVID-19 in hospitalized patients

被引:0
|
作者
Shostakovych-Koretskaya, L. R.
Kireyeva, T., V
Shevchenko-Makarenko, O. P.
Turchin, M.
Chumak, V. L.
Chortok, V
Drobyshevska, O. M.
机构
[1] Dnipro State Medical University, V. Vernadsky str., 9, Dnipro
[2] City Clinical Hospital No. 21 named after prof. Ye.G. Popkova, Kanatna str., 17, Dnipro
来源
MEDICNI PERSPEKTIVI | 2021年 / 26卷 / 04期
关键词
coronavirus disease; COVID-19; SARS-CoV-2; 2019-nCoV; pneumonia; antiviral therapy; invasive mechanical ventilation;
D O I
10.26641/2307-0404.2021.4.248085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prognostic predictors of an unfavorable course of coronavirus disease (COVID-19) and its complications with manifestations of pneumonia and the need for oxygen support and connection to the invasive mechanical ventilation were studied. Clinical and laboratory associations in hospitalized patients with COVID-19 were evaluated, the possible predictors of connection to the invasive mechanical ventilator in 37 patients were identified. Patients were hospitalized on day 6.65 +/- 3.32 of the disease, blood oxygen saturation (SpO2) depended on the severity of the disease and response to therapy. Positive significant correlations between the level of growth stimulating factor (ST2) and D-Dimer, creatine phosphokinase MB fraction (CPK-MB) and D-dimmer, CPK-MB and ST2 were revealed, as well as of ferritin and D-Dimer with ST2. There were no significant associations with troponin. C-reactive protein (CRP) probably correlated with CPK-MB and ferritin. The International Normalized Ratio (INR) indicator had significant correlations with D-dimmer, ST2 and CPK-MB. Cox regression analysis showed that the survival curve has a stepwised nature and the highest risk of deterioration, which requires mechanical ventilation, was noted on the 6th day of illness (95.0% CI = 0.9-1.0, with an average SpO(2) level =87.3%). ROC analysis showed the presence of a possible relationship between D-Dimer, ST2 protein, CPK-MB and the risk of developing a critical condition requiring mechanical ventilation in patients. The study showed that COVID-19 disease has a phase nature, when after the first phase of the disease, the pulmonary phase and hypercytokinemia progress in some patients with the development of hypoxia, a decrease in SpO(2). Therefore, the identification of markers of disease progression is essential for predicting the course and possible prevention of the development of acute respiratory distress syndrome with the use of invasive mechanical ventilation.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 50 条
  • [1] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    REHABILITATION, 2022, 61 (04) : 297 - 310
  • [2] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
    Platz, Thomas
    Dewey, Stefan
    Koellner, Volker
    Schlitt, Axel
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 981 - 988
  • [3] Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
    Ribeiro da Silva, Severino Jefferson
    Alves da Silva, Caroline Targino
    Guarines, Klarissa Miranda
    Germano Mendes, Renata Pessoa
    Pardee, Keith
    Kohl, Alain
    Pena, Lindomar
    ACS INFECTIOUS DISEASES, 2020, 6 (09): : 2319 - 2336
  • [4] Clinical characteristics of SARS-CoV-2 disease (COVID-19) in middle-aged patients
    Baletto, Ariel A.
    Gonzalo Acosta, S.
    Piasterlini, Franco
    Barrios, Cecilia
    Carboni Bisso, Indalecio
    Martinez Aquino, Eleno
    MEDICINA-BUENOS AIRES, 2021, 81 (03) : 401 - 407
  • [5] Cardiovascular effects of new coronavirus infection SARS-CoV-2 (COVID-19)
    Moreno-Martinez, Francisco L.
    Moreno-Lopez, Frank L.
    Oroz Moreno, Ricardo
    CORSALUD, 2020, 12 (01): : 3 - 17
  • [6] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
    Lai, Chih-Cheng
    Shih, Tzu-Ping
    Ko, Wen-Chien
    Tang, Hung-Jen
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [7] SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Van Vo, Giau
    Bagyinszky, Eva
    Park, Yoon Soo
    Hulme, John
    An, Seong Soo A.
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 3 - 19
  • [8] SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients
    de Sousa, Francisco Alves
    Costa, Rodrigo Pinto
    Xara, Sandra
    Pinto, Ana Nobrega
    Almeida e Sousa, Cecilia
    JOURNAL OF OTOLOGY, 2021, 16 (03) : 158 - 164
  • [9] Clinical symptom profile of hospitalized COVID-19 Brazilian patients according to SARS-CoV-2 variants
    Hojo-Souza, Natalia Satchiko
    Freitas, Vander Luis de Souza
    Guidoni, Daniel Ludovico
    de Souza, Fernanda Sumika Hojo
    EPIDEMIOLOGY AND HEALTH, 2023, 45 : 1 - 10
  • [10] SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
    Gozalbo-Rovira, Roberto
    Gimenez, Estela
    Latorre, Victor
    Frances-Gomez, Clara
    Albert, Eliseo
    Buesa, Javier
    Marina, Alberto
    Luisa Blasco, Maria
    Signes-Costa, Jaime
    Rodriguez-Diaz, Jesus
    Geller, Ron
    Navarro, David
    JOURNAL OF CLINICAL VIROLOGY, 2020, 131